Increasing ultraviolet light exposure is associated with reduced mortality from Clostridium difficile infection by Govani, Shail M et al.
Original Article
Increasing ultraviolet light exposure is
associated with reduced mortality from
Clostridium difficile infection
Shail M Govani1, Akbar K Waljee1,2, Ryan W Stidham1 and Peter DR Higgins1
Abstract
Background: Clostridium difficile infection (CDI) is an increasingly common cause of inpatient mortality. Vitamin D deficiency
is associated with more aggressive CDI. We aimed to determine if average annual ultraviolet light (UV) exposure was
associated with mortality in patients with CDI.
Methods: We used the US National Inpatient Sample (NIS) from 2004–2011 to assess the mortality risk in patients with a
diagnosis of CDI (as per ICD-9CM 008.45). Annual average state UV exposure was assigned to each hospitalization. Logistic
regression was used to determine the effects of UV exposure on mortality, controlling for age, gender, race and other
comorbidities.
Results: During the study period, there were 2.61 million hospitalizations with a diagnosis of CDI. The mortality rate was
9.0%. In univariate analysis, the odds ratio (OR) of inpatient mortality for the UV index was 0.97 (95% CI 0.95–0.99;
p¼ 0.008) per unit of UV exposure. In a multivariable model adjusting for age, gender, race, Charlson-Deyo index,
season and coexisting inflammatory bowel disease, the UV index remained a protective predictor, with an OR of 0.94
(95% CI 0.92–0.96; p< 0.001). In the multivariate model, a seasonal effect was also present, with the highest risk of inpatient
mortality in the period from January to March (OR 1.11; 95% CI 1.08–1.14) and the lowest risk, from July to September (OR
0.95; 95% CI 0.92–0.98).
Conclusions: An increase in UV exposure index is associated with a reduced risk of inpatient mortality in patients with CDI. A
seasonal effect is also present, with the highest risk of death during winter months. Further studies exploring the role of UV
light in CDI are necessary.
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Background
Clostridium difficile infection (CDI) is the most
common cause of infectious colitis in the USA, with a
fatality rate that increased from 1.2% in 2000 to 2.2%
in 2004.1 Risk factors for CDI include age, prior hos-
pitalizations, prior antibiotic use, proton pump inhibi-
tor use,2 inflammatory bowel diseases (IBD)3; and more
recently, there is also data to suggest that patients with
lower vitamin D levels have a more aggressive CDI
course.4
The importance of vitamin D in diseases beyond cal-
cium homeostasis and bone health is becoming more
apparent. Vitamin D has been found to have an anti-
microbial effect, aiding the macrophage suppression of
mycobacterial growth, in in vitro experiments.5 This
inhibition is believed to be mediated through the induc-
tion of cathelicidin, an antimicrobial peptide.6,7 Recent
in vitro and in vivo experiments in mice demonstrate
that exogenous administration of cathelicidin could
suppress intestinal damage due to CDI.8 In epidemio-
logical studies of patients who are critically ill,
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vitamin D deficiency is found to be a risk factor for
mortality.9 Additionally, studies of vitamin D and
CDI suggest that patients with vitamin D deficiency
have longer hospitalizations and increased healthcare-
associated costs.4
Sunlight, in the form of ultraviolet (UV) radiation,
provides a major source of vitamin D; UV-B radiation
converts 7-dehydrocholesterol into pre-vitamin D,
which is later converted to vitamin D3.10 The broad
importance of vitamin D in gut immunity is highlighted
by the finding of an inverse relationship between vita-
min D levels and the risk of diverticulitis.11 We aimed
to study whether UV light exposure is related to CDI
inpatient mortality, using the US National Inpatient
Sample (NIS) data from 2004 to 2011. We hypothesized
that patients in areas with more UV light exposure will
have lower mortality, adjusting for age, gender and
other comorbidities.
Methods
The NIS is a de-identified dataset of a 20% stratified
sample of inpatient hospitalizations. For this ana-
lysis, the 2004–2011 NIS datasets were used for ana-
lysis. Each hospitalization is characterized as a single
record, with discharge diagnoses, procedure codes
and socioeconomic data. The data abstraction pro-
cess to obtain UV exposure is described in detail, in
a prior publication.12 Briefly, annual UV light expos-
ure was obtained from published maps by the US
Environmental Protection Agency (EPA).13 These
maps showed the average UV index for each
month, from 2006–2010; the map was divided into
144 cells, which were then matched to the corres-
ponding 3-digit zip code (the first three digits of
the 5-digit zip code, designating one area within a
state). We calculated the average annual values per
3-digit zip code. These values were then validated, by
comparing the results to the 12-year average for 500
cities around the country. The level of UV exposure
was characterized by measurement of the UV index.
The UV index is a linear-scale prediction of the
ground level UV radiation, factoring in elevation,
cloud cover, ozone levels developed by the US
EPA and the US National Oceanic and
Atmospheric Association (NOAA).14 This value
ranges from 0 to greater than 11. As the zip-code
level data is only available for the hospital location,
and not for the patient’s home; and that data is
missing from 31.4% of hospitalizations, we elected
to calculate a state UV index average to apply to
each hospitalization. We calculated a Charlson-
Deyo comorbidity score for each hospitalization, in
order to factor in the effects of comorbidities on the
risk of mortality.15 We analyzed all hospitalizations
where CDI was a primary or a secondary diagnosis
(based on ICD9-CM code 008.45), as studies show
that primary ICD-9CM codes are valid and reliable
in large administrative datasets.16,17 In order to com-
pare hospitalization numbers across the country, the
UV index was categorized into approximately equal
population tertiles. We used US Census data from
2010 to determine state populations. Ulcerative col-
itis (UC) was classified as a diagnosis of ICD-9CM
code 556.X and Crohn’s disease was classified as a
diagnosis of ICD-9CM code 555.X. The ICD9-CM
diagnosis codes used for infection are located in
Supplementary Table 1.
Statistical analysis
We performed the statistical analysis using SAS 9.3
(Cary, NC, USA). The appropriate PROC SURVEY
commands were used, in order to generate national esti-
mates. The baseline characteristics of the population
were compared with the Rao-Scott chi-square test for
categorical variables or the student’s t-test for numer-
ical variables. We performed both univariate and multi-
variate logistic regression analysis, using PROC
SURVEYLOGISTIC, to determine individual effects
as odds ratios (ORs). All major clinical characteristics
and demographic characteristics were combined in the
multivariable model.
Results
In the US from 2004 to 2011, there were an esti-
mated 2.61 million (SD 61,110) hospitalizations with
a primary or secondary diagnosis of CDI. The overall
mortality rate for this group was 9.0%. Of these hos-
pitalizations, 790,854 were for primary diagnoses of
CDI. The mortality rate was 11.3% among those
with a secondary diagnosis, versus 3.5% among
those with a primary diagnosis. Patients who died
were more likely to be older (75.1 years versus 67.4
years, p< 0.001) and less likely to be female (54.2%
versus 58.3%, p< 0.001). Additionally, there were dif-
ferences in the insurance type and household income
between those whom survived and those whom
passed away (Table 1). The discharge quarter indi-
cated that a larger proportion of the deaths occurred
in the first one-half of the year, compared to later
months (p< 0.001).
The average national population-adjusted UV Index
was 4.59 (2010 US Census data). On the state level,
the average yearly UV Index ranged from 0.66 units
in AK, to 9.3 units in HI (Figure 1(a)). The average
UV exposure among hospitalizations that led to
mortality was lower (4.4 UV Index units versus
4.5, p¼ 0.009).
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Comparing the proportions of hospitalizations, we
found there was a significant difference in the percent-
age of hospitalizations across UV Index tertiles for
CDI, as compared to all hospitalizations (p< 0.001).
The largest proportion of hospitalizations was in the
lowest tertile of UV exposure (Figure 1(b)).
In a univariate analysis of mortality among those
with CDI, the factors of age, gender, insurance status,
as well as coexisting UC, infection and Charlson-Deyo
comorbidity index were all associated with mortality
(Table 2). The UV Index was inversely related to inpa-
tient mortality, with a 3% reduction in the odds of
death per 1-unit increase in UV Index among patients
with a primary or secondary diagnosis of CDI. For
comparison, among those with only a primary
diagnosis of CDI, the OR of inpatient mortality for
each unit increase in UV Index was 0.91 (95% CI
0.88–0.95; p< 0.001). The odds of inpatient mortality
were higher for hospitalizations occurring from
January to March, compared to the last 3 months of
the year. This is notable, as the nadir of vitamin D
serum levels occurs at the end of winter in the USA.
In order to control for important comorbidities and
age that are associated with mortality, a multivariate
model with the UV Index and these covariates was con-
structed (Table 3). Accounting for the Charlson-Deyo
comorbidity score, age, race, the patient’s inflammatory
bowel diseases, quarter of discharge from hospitaliza-
tion and co-existing bacterial infections, we found that
the mean annual UV Index remains a protective factor
Table 1. Baseline characteristics
Survived C. difficile infection
(n¼ 2,370,320)
Deceased from C. difficile infection
(n¼ 233,118)
Age (years) 67.4 (0.2) 75.1 (0.2)
Female (%) 58.3 (0.2) 54.2 (0.3)
Race (%)
Caucasian 75.6 (0.6) 75.3 (0.7)
African-American 11.7 (0.4) 11.4 (0.5)
Hispanic 7.8 (0.4) 7.7 (0.4)
Other 4.8 (0.2) 5.6 (0.3)
Payer Information (%)
Medicare 67.8 (0.4) 78.2 (0.4)
Medicaid 8.9 (0.2) 6.1 (0.2)
Private (including HMO) 19.2 (0.3) 12.6 (0.3)
Other 4.1 (0.1) 3.1 (0.1)
Median household income
Quartiles for patient’s Zip (%)
1–38,999 25.5 (0.6) 25.0 (0.7)
39,000–47,999 24.8 (0.5) 24.1 (0.6)
48,000–62,999 25.0 (0.4) 24.6 (0.5)
63,000þ 24.6 (0.8) 26.3 (1.0)
Discharge quarter (%)
January-March 25.7 (0.1) 27.7 (0.2)
April-June 25.9 (0.1) 25.9 (0.2)
July-September 24.3 (0.1) 22.6 (0.2)
October-December 24.1 (0.1) 23.7 (0.2)
Length of Stay (days) 12.3 (0.1) 16.7 (0.3)
Total charges ($US) 69,015.0 (1324.1) 126,774.9 (3207.3)
UC (%) 1.6 (0.03) 2.4 (0.09)
Crohn’s disease (%) 1.0 (0.03) 0.3 (0.03)
Co-existing bacterial infection (%) 29.8 (0.2) 66.7 (0.4)
Charlson-Deyo comorbidity score 1.9 (0.01) 2.4 (0.02)
Mean UV Index (units) 4.5 (0.03) 4.4 (0.03)
C. difficile: Clostridium difficile bacteria; HMO: health maintenance organization; UC: ulcerative colitis; UV: ultraviolet light ; Zip: US postal Zip code for
locations throughout the country.
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for inpatient CDI mortality. For each 5-unit increase in
the annual UV Index, the OR of inpatient mortality
(adjusting for these other important covariates) is
0.74, resulting in a 26% decrease in the odds of death.
We then tested this model in a series of sensitivity
analyses. As certain states (CA and CO) have high UV
standard deviations ( 0.5), we performed a sensitivity
analysis that excluded hospitalizations in those states.
This analysis returned essentially the same results for
UV Index effect on inpatient mortality in the multivari-
able model (OR¼ 0.93; 95% CI 0.91–0.95). With the
annual average UV Index for 3-digit zip codes, we were
able to perform an analysis on the subset of visits with
more localized zip code UV exposure data. This ana-
lysis once again showed a protective effect (Table 4).
Finally, we repeated our analysis excluding the state
of HI, due to the fact that the average annual UV Index
is much higher and the number of CDI-related deaths
in HI was quite low. This analysis again showed a
protective effect in a multivariate analysis (OR¼ 0.94;
95% CI 0.92–0.96). When only hospitalizations with a
primary diagnosis of CDI were considered in our ana-
lysis, UV Index again demonstrated a protective asso-
ciation with inpatient mortality (OR¼ 0.92; 95% CI
0.88–0.96; p< 0.001). In contrast to the association
between UV exposure and CDI mortality, an examin-
ation of all hospitalizations during the 8-year period
found that UV Index was not protective of all-cause
inpatient mortality (OR¼ 1.00; 95% CI 0.98–1.02;
p¼ 1.00).
Discussion
In this ecological study of NIS data from 2004–2011,
we found an inverse relationship between inpatient
mortality and the average yearly UV Index exposure
in patients with a diagnosis of CDI. Based on the esti-
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Figure 1. Color-coded geographic map of the USA demonstrates the average UV Index exposure per state, categorized by approximately
equal population tertiles. (a) The highest area of UV light exposure in the continental US is centered in the Southwest.18 (b) The
percentage breakdown of primary or secondary CDI diagnoses over the UV Index tertiles was statistically different from the breakdown of
hospitalizations without a CDI diagnosis.
Source: Govani SM, Higgins PDR, Stidham RW, et al. Increased Ultraviolet Light Exposure is Associated with Reduced Risk of Inpatient
Surgery Among Patients with Crohn’s Disease. J Crohn’s Colitis. 2015; 9: 77–81.
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Table 2. Univariate ORs of inpatient mortality in patients with CDI
Predictor OR of mortality 95% CI p value
Age (per year) 1.03 1.026–1.028 <0.001
Race




Female vs. male gender 0.85 0.83–0.86 <0.001
Payer




Median household income quartiles for patient’s zip




UC 1.50 1.39–1.61 <0.001
Crohn’s disease 0.32 0.27–0.38 <0.001
Co-existing bacterial infection 4.73 4.59–4.87 <0.001
Charlson-Deyo (per 1 unit) 1.15 1.14–1.15 <0.001
Mean UV (per 1 unit) 0.97 0.95–0.99 0.008
Discharge quarter




CDI: Clostridium difficile infection; OR: odds ratio; UC: ulcerative colitis; UV: ultraviolet light; Zip: postal US Zip code.
Table 3. Multivariate ORs of inpatient mortality among patients with CDI
Predictor OR 95% CI p value






Female vs. male 0.88 0.86–0.90 <0.001
UC 1.90 1.76–2.05 <0.001
Crohn’s disease 0.67 0.56–0.80 <0.001
Co-existing bacterial infection 4.80 4.64–4.95 <0.001
Charlson-Deyo (per 1 unit) 1.15 1.14–1.16 <0.001
Mean UV Index (per 1 unit) 0.94 0.92–0.96 <0.001
Discharge quarter




CDI: Clostridium difficile infection; OR: odds ratio; UC: ulcerative colitis.
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16% less likely to die in the hospital from CDI than a
patient of the same age, gender and other comorbidities
in MI.
While there are a number of studies showing an
association between latitude and the incidence of
inflammatory bowel diseases,19,20 this is the first study
that we know of that has examined the association
between UV exposure and hospitalizations for CDI.
The strengths of this study include the size of the data-
base, which represents more than 200 million hospital-
izations in the US over an 8-year period and includes
extensive discharge diagnosis data, demographics and
comorbidity data. The significance of discharge quarter
in the multivariable model is further evidence that the
protective effect of UV light may be mediated through
vitamin D. A recent study of the season variation of
vitamin D revealed a peak serum vitamin D in August
and a nadir in February.21 Our study found that the
last quarter of the year had lower inpatient mortality,
which could be due to the delayed response of vitamin
D levels to summer UV exposure.
The study’s major limitations included the fact that
it was based on administrative data, which may have
imperfect discharge coding, and that the associations
seen here could possibly be due to another unknown
factor. We focused our analysis on hospitalizations
with primary or secondary diagnoses of CDI, in order
to capture patients in whom CDI was the major diag-
nosis (and therefore, a main contributor to mortality).
We note that the mortality rate among patients with a
primary diagnosis of CDI is 3.5%, which is lower than
the mortality rate among those with a secondary diag-
nosis (11.3%). While we studied the association
between UV and mortality among patients with CDI,
we do not have a method to determine whether the
cause of death was due to CDI; however, the
association between UV exposure and inpatient mortal-
ity was stronger for patients with only a primary diag-
nosis of CDI. Our data cannot account for migratory
patterns of Americans or other confounding exposures
that may be more likely to occur in the US South/
Southwest and could be protective against CDI mortal-
ity. Additionally, the dataset did not allow for adjust-
ment for other important predictors of CDI, such as
serum albumin, proton pump inhibitor use or white
blood cell count.
While we hypothesize that the protective effect of
UV light on CDI mortality is mediated through
increased levels of vitamin D, it is possible that sunlight
and/or warmth itself may have some protective effect. It
is also possible that an indirectly associated factor, i.e.
use of sunscreen, could be protective rather than UV
light or vitamin D. In animal models of multiple scler-
osis, an autoimmune disease with similar geographic
associations as CD, it was shown that UV light has a
beneficial effect, independent of vitamin D levels.22,23
Future studies will need to be done in other large
datasets, to see if the relationship between CDI mortal-
ity and UV light persists. With the increasing incidence
of CDI and the high prevalence of vitamin D deficiency
in the elderly population, further research is needed to
confirm this association and to determine whether
interventions such as vitamin D supplementation can
change CDI outcomes.
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